Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

antibodies

Covid-19 in South Africa: Which approach should we take now?
Coronavirus
/ 3 February 2022

Covid-19 in South Africa: Which approach should we take now?

The trick to tackling Covid-19 at this stage is to be adaptive. The government’s one-size-fits-all approach is broken; we need to be more flexible. But we should not throw away hard-won lessons

By Philip Machanick
Unvaccinated, untreated: Africa may not get its fair share of Covid-19 drugs
Africa
/ 26 August 2021

Unvaccinated, untreated: Africa may not get its fair share of Covid-19 drugs

Only 18 countries are using dexamethasone, while tocilizumab and sarilumab can cost hundreds or thousands of dollars a dose

By Laura López González
Covid-19 crash course: Everything you need to know about viruses, variants and vaccines
Coronavirus
/ 12 August 2021

Covid-19 crash course: Everything you need to know about viruses, variants and vaccines

Covid-19 variants are new versions of the virus that are smarter at surviving. But before we can understand what these changed forms mean for vaccines, we first need to go back to the basics. We take you through the evolution of the virus and what this means for your body’s defences.

By Belinda Beresford
No silver bullet for Covid-19, but rather a cocktail
Health
/ 14 February 2021

No silver bullet for Covid-19, but rather a cocktail

It is no good waiting for a vaccine or ivermectin or other miracle cures, we just need to do what we can do now

By Philip Machanick
Universities rally to fight pandemic
Coronavirus
/ 7 May 2020

Universities rally to fight pandemic

These institutions are a crucial part of the research and development process that underpins South Africa’s life-and-death fight against the Covid-19 outbreak

By Athandiwe Saba

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }